Abstracts
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Hamburg University, Hamburg, Germany, 2 The Queen Silvia Children's Hospital, Göteborg, Sweden, 3 Hôpital des enfants, Toulouse, France, 4 Insight Consulting & Research S.L., Barcelona, Spain, 5 Pfizer Incorporated, San Diego, CA, USA, 6 University of Edinburgh, Edinburgh, UK, 7 Pfizer, Ltd, Walton Oaks, UK OBJECTIVES: Since pediatric growth disorders such as Growth Hormone Deficiency (GHD) and Idiopathic Short Stature (ISS) might affect subjective wellbeing and functioning, treatment outcomes should include assessment of quality of life (QoL). The multinational QoLISSY project aims at developing simultaneously in 5 countries, a targeted instrument to measure outcomes in short stature children in three age groups (4-7, 8-12, & 13-18 yrs.) . METHODS: The project follows international instrument development guidelines and uses focus groups, cognitive interviewing, and pilot-and field testing. Per country, 24 children (height <−2 SDS) and one of their parents were recruited into focus groups according to age group (8-12 and 13-18 yrs.), gender, diagnosis (ISS/GHD) and GH-treatment (treated and non-treated). Statements derived from focus groups were used to formulate items which were subsequently presented to 24 child-parent pairs per country for cognitive debriefing. Additional focus groups with parents of very young children were also conducted. RESULTS: The focus groups included 96 children (age 8-18), 126 parent participants, as well as 38 parents of young children (4-7 yrs.). All material was transcribed and relevant passages reduced to statements (1800 child, 2500 adult) which were further reduced to items (170 child, 209 adult) . CONCLUSIONS: This process provided rich material for further analysis and a sound basis for pilot testing. Short stature appears to be a main focus of attention for children and their parents, with teasing and bullying as frequent experiences. Some inter-individual and cross-cultural differences in concepts were found, suggesting a more complex model for understanding wellbeing and functioning than first envisioned. These preliminary results showed that a comprehensive taxonomy of psychological outcomes is needed as well as more research regarding the effects of psychological and medical treatment on quality of life of short stature children and their families.
PDB49 AGE-SPECIFIC ORIGINALS: USING THE PEDIATRIC QUALITY OF LIFE™ (PEDSQL™) DIABETES MODULE TO STUDY SIMILARITIES AND DIFFERENCES IN TARGET LANGUAGES
Neewoor S 1 , Varni JW 2 1 MAPI Institute, Lyon, France, 2 Texas A&M University, College Station, TX, USA OBJECTIVES: Prior to use in an international study, the PedsQL™ 3.2 Diabetes Module consisting of 5 reports (Teen report, Adult report, Child report, Parent report for teens, Parent report for children) underwent linguistic validation into 10 languages. A rigorous methodology was conducted to ensure conceptual equivalence, cultural relevance and appropriateness of formulations across the 3 age categories. This involved forward / backward translations and testing on a sample of the 3 age groups. 29 out of 32 items being identical in the original, the aim of our study was to investigate if this was the case in the translations, determine a potential pattern should there be differences and make recommendations on the basis of the results. METHODS: This investigation was carried out as follows: 1) Comparison of the 29 identical items across the Teen, Adult and Child reports in the 10 translations; 2) identification of differences across the three reports; and 3) determination of a pattern in the differences. RESULTS: First results indicate that language versions are relatively similar across the 3 reports with few differences and no identifiable pattern. The differing formulations across age groups are not the same across translations. Differences are not linked to the translation of technical terms, but found in items on general symptoms. CONCLUSIONS: The similarities across the 3 age-specific forms for the 10 languages seem to indicate the universal and intergenerational acceptability of the original concepts and their formulations. Given the differences without identifiable pattern across age categories in some languages however, it is recommended to test the understanding of each item through cognitive debriefing on a sample of each age group despite the use of identical formulations in the original. This will ensure appropriate comprehension across age groups and translations and facilitate international comparison and pooling of data. The study population consisted of patients aged 18-64 with diabetes, but without immunodeficiency, malignancy, kidney dialysis, or underweight. Diabetic patients' QOL were classified as low (≤25%), medium ( > 25%-< 75%), and high (≥75%) based on quartiles of the SF-12 physical component scale(PCS-12) and mental component scale(MCS-12) respectively. Patients' BMI was classified as normal, overweight, and obese. Diabetic complications included heart disease, stroke, retinopathy, neuropathy, and nephropathy. MCs were estimated using a generalized linear regression model with log link and gamma distribution after adjusting for patient characteristics and comorbidities. LPC were calculated based on missed working days due to illness and average hourly wage using a two part model for working adults. All costs were converted to 2008 U.S. dollars. RESULTS: The study identified 3,621 diabetic patients. Patients with low PCS-12 had more complications, compared to those with high . A similar trend was also observed for . In general, patients with lower PCS-12 had higher MC ($12, and LPC ($1,632 in low-QOL vs. $293 in high-QOL). A similar trend was found in the relationship between MCS-12 and both costs, but this relationship was weaker than that of PCS-12. Among patients with medium to high PCS-12, obese patients had higher MC and LPC than normal or overweight patients. CONCLUSIONS: Lower levels of QOL were associated with a higher economic burden on diabetic patients, especially the physical QOL component. Among diabetic patients with higher levels of physical QOL that are less confounded by disease severity and complications, the impact of obesity on economic burden was observed. The objective of the study was to understand of the impact of diabetesrelated non-severe hypoglycemic episodes (NSHE's) on work productivity and diabetes management. METHODS: A web-based survey was developed based on literature, expert input and 68 patients participating in focus-group or individual interviews. Persons with self-reported diabetes in US, France, Germany, and UK participated in the survey. NSHE's were classified as occurring in the past month, either daytime (while at work or not at work) or during sleep. RESULTS: A total of 6756 persons were surveyed of whom 972 (14.4%) worked for pay and had a NSHE. The mean age of the sample was 41.3 ± 13.5. There were no significant country differences for % on insulin vs. oral or % type1 vs. type 2 subjects. Fifty-nine percent of type 1 subjects (range 50.7% in France -70.9% in US, p = 0.001) and 34.8% of type 2
PDB50 THE IMPACT OF OBESITY AND QUALTY OF LIFE ON MEDICAL AND LOST PRODUCTIVITY COSTS IN DIABETIC PATIENTS

PDB51 THE IMPACT OF NON-SEVERE HYPOGLYCEMIC EPISODES ON WORK PRODUCTIVITY AND DIABETES MANAGEMENT: A FOUR COUNTRY PERSPECTIVE
